Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates
Antibodies dovetail with protection
Immune correlates of protection are clinical end points used to gauge vaccine-induced immunogenicity and protection. Corbett et al . studied nonhuman primate (NHP) immune responses to various doses of the mRNA-1273 (Moderna) vaccine to provide a range of immune responses and protective outcomes. They determined that circulating spike protein–specific antibodies correlated with protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in the airways. Passively transferred NHP antibodies were sufficient to mediate protection against SARS-CoV-2 challenge in hamsters, emphasizing that antibodies are mechanistic correlates. Protection of the lower respiratory tract required lower serum antibody concentrations, possibly explaining why most current vaccines are highly effective against severe lower airway disease. The higher antibody threshold required for reducing upper airway infection has potential implications for boosting to limit transmission. —STS
Топ-30
Журналы
|
2
4
6
8
10
12
14
16
18
|
|
|
bioRxiv
17 публикаций, 6.42%
|
|
|
Nature Communications
15 публикаций, 5.66%
|
|
|
Frontiers in Immunology
13 публикаций, 4.91%
|
|
|
npj Vaccines
11 публикаций, 4.15%
|
|
|
Cell
10 публикаций, 3.77%
|
|
|
Science Translational Medicine
8 публикаций, 3.02%
|
|
|
Vaccines
8 публикаций, 3.02%
|
|
|
Science
5 публикаций, 1.89%
|
|
|
Viruses
5 публикаций, 1.89%
|
|
|
EBioMedicine
5 публикаций, 1.89%
|
|
|
Vaccine
5 публикаций, 1.89%
|
|
|
PLoS Pathogens
5 публикаций, 1.89%
|
|
|
Immunity
4 публикации, 1.51%
|
|
|
iScience
4 публикации, 1.51%
|
|
|
Science advances
4 публикации, 1.51%
|
|
|
Science immunology
4 публикации, 1.51%
|
|
|
Clinical Infectious Diseases
4 публикации, 1.51%
|
|
|
JCI insight
3 публикации, 1.13%
|
|
|
Nature Immunology
3 публикации, 1.13%
|
|
|
Human Vaccines and Immunotherapeutics
3 публикации, 1.13%
|
|
|
Open Forum Infectious Diseases
3 публикации, 1.13%
|
|
|
Journal of Infectious Diseases
3 публикации, 1.13%
|
|
|
Microbiology spectrum
3 публикации, 1.13%
|
|
|
Microorganisms
2 публикации, 0.75%
|
|
|
Nature Microbiology
2 публикации, 0.75%
|
|
|
Signal Transduction and Targeted Therapy
2 публикации, 0.75%
|
|
|
Nature Medicine
2 публикации, 0.75%
|
|
|
Antiviral Research
2 публикации, 0.75%
|
|
|
PLoS ONE
2 публикации, 0.75%
|
|
|
2
4
6
8
10
12
14
16
18
|
Издатели
|
10
20
30
40
50
60
|
|
|
Cold Spring Harbor Laboratory
54 публикации, 20.38%
|
|
|
Elsevier
46 публикаций, 17.36%
|
|
|
Springer Nature
44 публикации, 16.6%
|
|
|
American Association for the Advancement of Science (AAAS)
21 публикация, 7.92%
|
|
|
MDPI
17 публикаций, 6.42%
|
|
|
Frontiers Media S.A.
16 публикаций, 6.04%
|
|
|
Wiley
13 публикаций, 4.91%
|
|
|
Oxford University Press
11 публикаций, 4.15%
|
|
|
American Society for Microbiology
9 публикаций, 3.4%
|
|
|
Public Library of Science (PLoS)
7 публикаций, 2.64%
|
|
|
Taylor & Francis
5 публикаций, 1.89%
|
|
|
American Society for Clinical Investigation
4 публикации, 1.51%
|
|
|
SAGE
3 публикации, 1.13%
|
|
|
American College of Physicians
1 публикация, 0.38%
|
|
|
Massachusetts Medical Society
1 публикация, 0.38%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 публикация, 0.38%
|
|
|
American Chemical Society (ACS)
1 публикация, 0.38%
|
|
|
The American Association of Immunologists
1 публикация, 0.38%
|
|
|
BMJ
1 публикация, 0.38%
|
|
|
American Society of Hematology
1 публикация, 0.38%
|
|
|
American Society of Clinical Oncology (ASCO)
1 публикация, 0.38%
|
|
|
Annual Reviews
1 публикация, 0.38%
|
|
|
American Society for Cell Biology (ASCB)
1 публикация, 0.38%
|
|
|
Research Square Platform LLC
1 публикация, 0.38%
|
|
|
Cambridge University Press
1 публикация, 0.38%
|
|
|
Royal Society of Chemistry (RSC)
1 публикация, 0.38%
|
|
|
10
20
30
40
50
60
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.